Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by eric40on Apr 08, 2019 9:32am

191 Views

Post# 29595856

RE:Éric40

Your right the pipeline is still there, but the money and credibility is gone. Prometic will take what will be offer to avoid bankruptcy. So it is up to Thomvest and future financing partners to call the shot.

I

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta